Indian Journal of Dermatology
REVIEW ARTICLE
Year
: 2018  |  Volume : 63  |  Issue : 5  |  Page : 361--368

Antifungal resistance in dermatology


Varadraj Pai1, Ajantha Ganavalli2, Naveen Narayanshetty Kikkeri3 
1 Department of Dermatology, Goa Medical College, Bambolim, Goa, India
2 Department of Microbiology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India
3 Department of Dermatology, SDM College of Medical Sciences and Hospital, Dharwad, Karnataka, India

Correspondence Address:
Dr. Varadraj Pai
Department of Dermatology, Goa Medical College, Bambolim, Goa
India

Cutaneous fungal infections affect more than one-fourth of world's population. The pathogenesis and severity of fungal infection depend on various immunological and nonimmunological factors. The rampant use of antifungal therapy in immunocompromised individuals marked the onset of antifungal drug resistance. Fungal resistance can be microbiological or clinical. Microbiological resistance depends on various fungal factors which have established due to genetic alteration in the fungi. Clinical resistance is due to host- or drug-related factors. All these factors may cause fungal resistance individually or in tandem. In addition to standardized susceptibility testing and appropriate drug dosing, one of the ways to avoid resistance is the use of combinational antifungal therapy. Combination therapy also offers advantages in increased synergistic action with enhanced spectrum activity. Newer insights into mechanisms of drug resistance will help in the development of appropriate antifungal therapy.


How to cite this article:
Pai V, Ganavalli A, Kikkeri NN. Antifungal resistance in dermatology.Indian J Dermatol 2018;63:361-368


How to cite this URL:
Pai V, Ganavalli A, Kikkeri NN. Antifungal resistance in dermatology. Indian J Dermatol [serial online] 2018 [cited 2020 Jul 11 ];63:361-368
Available from: http://www.e-ijd.org/article.asp?issn=0019-5154;year=2018;volume=63;issue=5;spage=361;epage=368;aulast=Pai;type=0